Clinical Trials in Arendal, Norway
3 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company700 enrolled353 locationsNCT06890598
Recruiting
Not Applicable
Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance
Colorectal Neoplasms
Sorlandet Hospital HF4,000 enrolled1 locationNCT06983639
Recruiting
Phase 2
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Parkinson's DiseaseParkinson Disease (PD)
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
Plasma Cell LeukemiaMyeloma, MultipleAL Amyloidosis
St. Olavs Hospital400 enrolled23 locationsNCT06855121